ai3Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $48M

  • Investors
  • 4

ai3Bio General Information

Description

Developer of biotechnology therapeutics designed to selectively eliminate disease-causing T cells for the treatment of autoimmune diseases. The company develops LNP/mRNA and antibody-based therapeutic platforms targeting pathogenic Th17 and other inflammatory T cells, enabling patients to achieve lasting remission from inflammatory disorders without broadly suppressing their body's natural defenses.

Contact Information

Website
www.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 99 Coolidge Avenue
  • Suite 201
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 99 Coolidge Avenue
  • Suite 201
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ai3Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 29-Sep-2026 $48M Completed Pre-Clinical Trials
To view ai3Bio’s complete valuation and funding history, request access »

ai3Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
Seed 5
Seed 4
Seed 3
Seed 2 54,579,076 $0.000100 6% $0.29 $0.29 1x $0.29 0.06%
Seed 1 4,803,835 $0.000100 6% $0.68 $0.68 1x $0.68 0%
To view ai3Bio’s complete cap table history, request access »

ai3Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cockrell Interests Family Office Minority
Tanis Venture Management Venture Capital Minority
UPMC Enterprises Corporate Venture Capital Minority
Ziff Capital Partners Family Office Minority
To view ai3Bio’s complete investors history, request access »

ai3Bio FAQs

  • Where is ai3Bio headquartered?

    ai3Bio is headquartered in Watertown, MA.

  • What industry is ai3Bio in?

    ai3Bio’s primary industry is Drug Discovery.

  • Is ai3Bio a private or public company?

    ai3Bio is a Private company.

  • What is the current valuation of ai3Bio?

    The current valuation of ai3Bio is .

  • What is ai3Bio’s current revenue?

    The current revenue for ai3Bio is .

  • How much funding has ai3Bio raised over time?

    ai3Bio has raised $48M.

  • Who are ai3Bio’s investors?

    Cockrell Interests, Tanis Venture Management, UPMC Enterprises, and Ziff Capital Partners have invested in ai3Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process